Form 8-K - Current report:
SEC Accession No. 0001193125-24-273896
Filing Date
2024-12-10
Accepted
2024-12-10 06:05:55
Documents
18
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d905678d8k.htm   iXBRL 8-K 35847
2 EX-10.1 d905678dex101.htm EX-10.1 48411
3 EX-10.2 d905678dex102.htm EX-10.2 41929
4 EX-10.3 d905678dex103.htm EX-10.3 41968
5 EX-10.4 d905678dex104.htm EX-10.4 41317
  Complete submission text file 0001193125-24-273896.txt   423857

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241209.xsd EX-101.SCH 3912
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241209_def.xml EX-101.DEF 13702
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241209_lab.xml EX-101.LAB 22564
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241209_pre.xml EX-101.PRE 14671
21 EXTRACTED XBRL INSTANCE DOCUMENT d905678d8k_htm.xml XML 5696
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241537022
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)